GB Patent

GB2067900A — Tablets containing trimethoprim, sulphamethoxazole and polyvinylpyrrolidone

Assigned to DDSA Pharmaceuticals Ltd · Expires 1981-08-05 · 45y expired

What this patent protects

Co-trimoxazole tablets and dispersible tablets are prepared by formulating trimethoprim and sulphamethoxazole with polyvinylpyrrolidone preferably insoluble as a disintegrating agent. Magnesium stearate is preferably included as a lubricant and conventional polyvinylpyrrolidone a…

USPTO Abstract

Co-trimoxazole tablets and dispersible tablets are prepared by formulating trimethoprim and sulphamethoxazole with polyvinylpyrrolidone preferably insoluble as a disintegrating agent. Magnesium stearate is preferably included as a lubricant and conventional polyvinylpyrrolidone as binder.

Drugs covered by this patent

Patent Metadata

Patent number
GB2067900A
Jurisdiction
GB
Classification
—
Expires
1981-08-05
Drug substance claim
No
Drug product claim
No
Assignee
DDSA Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.